← 產業報告目錄
Clinical Oncology Next Generation Sequencing Market Size, Share & Trends Analysis Report By Application Type (Screening, Companion Diagnostics, and Other Diagnostics), By End User (Hospitals, Clinics, and Laboratories), By Technology Type (Whole Genome Sequencing, Whole Exome Sequencing, and Targeted Sequencing & Resequencing), By Workflow Type (NGS Pre-Sequencing, NGS Sequencing, and NGS Data Analysis), By Region, And By Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-02-08頁數 179報告編號 INSIGHTACE-f48ef7b4da
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The worldwide Clinical Oncology Next Generation Sequencing Market stood at USD 474.2 Mn in 2024, and is anticipated to reach USD 2,069.7 Mn by 2034, recording a CAGR of 16.0% from 2025 through 2034.
Clinical Oncology Next Generation Sequencing encompasses key industry insights & findings from the report:
the global clinical oncology next-generation sequencing market is poised for pronounced growth, driven by the surging adoption of ngs technologi. The sector has gained traction as organizations seek innovative approaches to address evolving healthcare challenges.
Several factors contribute to this trajectory, including heightened appetite for next-generation products, expanding applications across diverse end-use sectors, and supportive government initiatives.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
From a regional perspective, mature markets in North America and Europe continue to hold pronounced shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and surging investment in the sector.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Clinical Oncology Next Generation Sequencing Market Snapshot
Chapter 4. Global Clinical Oncology Next Generation Sequencing Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Application Type Estimates & Trend Analysis
5.1. By Application Type, & Market Share, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Application Type:
5.2.1. Screening
5.2.2. Companion Diagnostics
5.2.3. Other Diagnostics
Chapter 6. Market Segmentation 2: By End User Estimates & Trend Analysis
6.1. By End User & Market Share, 2023 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By End User:
6.2.1. Hospitals
6.2.2. Clinics
6.2.3. Laboratorie
Chapter 7. Market Segmentation 3: By Technology Type Estimates & Trend Analysis
7.1. By Technology Type & Market Share, 2023 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Technology Type:
7.2.1. Whole Genome Sequencing
7.2.2. Whole Exome Sequencing
7.2.3. Targeted Sequencing & Resequencing
Chapter 8. Market Segmentation 4: By Workflow Type Estimates & Trend Analysis
8.1. By Workflow Type & Market Share, 2023 & 2031
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Workflow Type:
8.2.2. NGS Pre-Sequencing
8.2.3. NGS Sequencing
8.2.4. NGS Data Analysis
Chapter 9. Clinical Oncology Next Generation Sequencing Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Clinical Oncology Next Generation Sequencing Market revenue (US$ Million) estimates and forecasts By Application Type, 2021-2034
9.1.2. North America Clinical Oncology Next Generation Sequencing Market revenue (US$ Million) estimates and forecasts By End User, 2021-2034
9.1.3. North America Clinical Oncology Next Generation Sequencing Market revenue (US$ Million) estimates and forecasts By Technology Type, 2021-2034
9.1.4. North America Clinical Oncology Next Generation Sequencing Market revenue (US$ Million) estimates and forecasts By Workflow Type, 2021-2034
9.1.5. North America Clinical Oncology Next Generation Sequencing Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
9.2. Europe
9.2.1. Europe Clinical Oncology Next Generation Sequencing Market revenue (US$ Million) By Application Type, 2021-2034
9.2.2. Europe Clinical Oncology Next Generation Sequencing Market revenue (US$ Million) By End User, 2021-2034
9.2.3. Europe Clinical Oncology Next Generation Sequencing Market revenue (US$ Million) By Technology Type, 2021-2034
9.2.4. Europe Clinical Oncology Next Generation Sequencing Market revenue (US$ Million) By Workflow Type, 2021-2034
9.2.5. Europe Clinical Oncology Next Generation Sequencing Market revenue (US$ Million) by country, 2021-2034
9.3. Asia Pacific
9.3.1. Asia Pacific Clinical Oncology Next Generation Sequencing Market revenue (US$ Million) By Application Type, 2021-2034
9.3.2. Asia Pacific Clinical Oncology Next Generation Sequencing Market revenue (US$ Million) By End User, 2021-2034
9.3.3. Asia Pacific Clinical Oncology Next Generation Sequencing Market revenue (US$ Million) By Technology Type, 2021-2034
9.3.4. Asia Pacific Clinical Oncology Next Generation Sequencing Market revenue (US$ Million) By Workflow Type, 2021-2034
9.3.5. Asia Pacific Clinical Oncology Next Generation Sequencing Market revenue (US$ Million) by country, 2021-2034
9.4. Latin America
9.4.1. Latin America Clinical Oncology Next Generation Sequencing Market revenue (US$ Million) By Application Type, 2021-2034
9.4.2. Latin America Clinical Oncology Next Generation Sequencing Market revenue (US$ Million) By End User, 2021-2034
9.4.3. Latin America Clinical Oncology Next Generation Sequencing Market revenue (US$ Million) By Technology Type, 2021-2034
9.4.4. Latin America Clinical Oncology Next Generation Sequencing Market revenue (US$ Million) By Workflow Type, 2021-2034
9.4.5. Latin America Clinical Oncology Next Generation Sequencing Market revenue (US$ Million) by country, 2021-2034
9.5. Middle East & Africa
9.5.1. Middle East & Africa Clinical Oncology Next Generation Sequencing Market revenue (US$ Million) By Application Type, 2021-2034
9.5.2. Middle East & Africa Clinical Oncology Next Generation Sequencing Market revenue (US$ Million) By End User, 2021-2034
9.5.3. Middle East & Africa Clinical Oncology Next Generation Sequencing Market revenue (US$ Million) By Technology Type, 2021-2034
9.5.4. Middle East & Africa Clinical Oncology Next Generation Sequencing Market revenue (US$ Million) By Workflow Type, 2021-2034
9.5.5. Middle East & Africa Clinical Oncology Next Generation Sequencing Market revenue (US$ Million) by country, 2021-2034
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. llumina Inc.
10.2.2. Thermo Fisher Scientific
10.2.3. F. Hoffmann-La Roche Ltd.
10.2.4. Agilent Technologies
10.2.5. Myriad Genetics
10.2.6. Perkin Elmer
10.2.7. Caris Life Sciences
10.2.8. Partek, Inc.
10.2.9. Eurofins Scientific
10.2.10. Qiagen N.V.
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們